相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Herpes simplex virus: global infection prevalence and incidence estimates, 2016
Charlotte James et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2020)
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
Clare Burn Aschner et al.
VACCINES (2020)
A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection
Lesia K. Dropulic et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Therapeutic HSV-2 vaccine decreases recurrent virus shedding and recurrent genital herpes disease
David Bernstein et al.
VACCINE (2019)
Laboratory Diagnosis of Neonatal Herpes Simplex Virus Infections
William J. Muller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Immune responses to a HSV-2 polynucleotide immunotherapy COR-1 in HSV-2 positive subjects: A randomized double blinded phase I/IIa trial
Janin Chandra et al.
PLOS ONE (2019)
Varicella and herpes zoster vaccine development: lessons learned
Charlotte Warren-Gash et al.
EXPERT REVIEW OF VACCINES (2017)
Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV)
Folasade Arinze et al.
INFECTION (2017)
Interaction between herpesvirus entry mediator and HSV-2 glycoproteins mediates HIV-1 entry of HSV-2-infected epithelial cells
Kai Hu et al.
JOURNAL OF GENERAL VIROLOGY (2017)
A model of genital herpes simplex virus Type 1 infection in Rhesus Macaques
Meropi Aravantinou et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2017)
Prevalence, incidence and correlates of HSV-2 infection in an HIV incidence adolescent and adult cohort study in western Kenya
Brenda Akinyi et al.
PLOS ONE (2017)
Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding
Christine Johnston et al.
CLINICAL MICROBIOLOGY REVIEWS (2016)
Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period
Petra J. Woestenberg et al.
BMC INFECTIOUS DISEASES (2016)
Human papillomavirus vaccination induces neutralising antibodies in oral mucosal fluids
A. Handisurya et al.
BRITISH JOURNAL OF CANCER (2016)
Herpes Genitalis: Diagnosis, Treatment and Prevention
A. Sauerbrei
GEBURTSHILFE UND FRAUENHEILKUNDE (2016)
A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs
Jared M. Odegard et al.
VACCINE (2016)
An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1
Julie L. Dutton et al.
Human Vaccines & Immunotherapeutics (2016)
Two fatal herpesvirus cases: Treatable but easily missed diagnoses
Christine Bookhout et al.
IDCASES (2016)
Herpes Simplex Virus: The Interplay Between HSV, Host, and HIV-1
Dipen Vijay Desai et al.
VIRAL IMMUNOLOGY (2015)
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
Katharine J. Looker et al.
PLOS ONE (2015)
Herpes simplex virus-2 transmission probability estimates based on quantity of viral shedding
Joshua T. Schiffer et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
Vaccination with a HSV-2 UL24 mutant induces a protective immune response in murine and guinea pig vaginal infection models
Robert J. Visalli et al.
VACCINE (2014)
Current status and prospects for development of an HSV vaccine
Christine Johnston et al.
VACCINE (2014)
HSV-2 Vaccine: Current Status and Insight into Factors for Developing an Efficient Vaccine
Xiao-Peng Zhu et al.
VIRUSES-BASEL (2014)
Herpes simplex virus drug-resistance: new mutations and insights
Graciela Andrei et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2013)
An Adjuvanted Herpes Simplex Virus 2 Subunit Vaccine Elicits a T Cell Response in Mice and Is an Effective Therapeutic Vaccine in Guinea Pigs
Mojca Skoberne et al.
JOURNAL OF VIROLOGY (2013)
Pan-HSV-2 IgG Antibody in Vaccinated Mice and Guinea Pigs Correlates with Protection against Herpes Simplex Virus 2
William P. Halford et al.
PLOS ONE (2013)
A Novel DNA Vaccine Technology Conveying Protection against a Lethal Herpes Simplex Viral Challenge in Mice
Julie L. Dutton et al.
PLOS ONE (2013)
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: Results from a randomised, controlled, double-blind trial
Jan Hendrik Richardus
VACCINE (2013)
Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection
Mark Shlapobersky et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread
Sita Awasthi et al.
JOURNAL OF VIROLOGY (2012)
Efficacy Results of a Trial of a Herpes Simplex Vaccine
Robert B. Belshe et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Immunogenicity and Efficacy of Intramuscular Replication-Defective and Subunit Vaccines against Herpes Simplex Virus Type 2 in the Mouse Genital Model
Simon Delagrave et al.
PLOS ONE (2012)
Resistance of Herpes Simplex Viruses to Nucleoside Analogues: Mechanisms, Prevalence, and Management
Jocelyne Piret et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Genital Shedding of Herpes Simplex Virus Among Symptomatic and Asymptomatic Persons With HSV-2 Infection
Elizabeth Tronstein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
A5-Positive Primary Sensory Neurons Are Nonpermissive for Productive Infection with Herpes Simplex Virus 1 In Vitro
Andrea S. Bertke et al.
JOURNAL OF VIROLOGY (2011)
A Live-Attenuated HSV-2 ICP0- Virus Elicits 10 to 100 Times Greater Protection against Genital Herpes than a Glycoprotein D Subunit Vaccine
William P. Halford et al.
PLOS ONE (2011)
A heat shock protein based polyvalent vaccine targeting HSV-2: CD4+ and CD8+ cellular immunity and protective efficacy
Annie Mo et al.
VACCINE (2011)
Safety and immunogenicity of long HSV-2 peptides complexed with rhHsc70 in HSV-2 seropositive persons
Anna Wald et al.
VACCINE (2011)
Immunogenicity and Safety of Intradermal Influenza Vaccination in Healthy Older Adults
Ru-Chien Chi et al.
CLINICAL INFECTIOUS DISEASES (2010)
Safety and Immunogenicity of Modified Vaccinia Ankara (ACAM3000): Effect of Dose and Route of Administration
Marissa B. Wilck et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
HPV vaccine: an overview of immune response, clinical protection, and new approaches for the future
Luciano Mariani et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
Herpes Simplex Virus 2 ICP0- Mutant Viruses Are Avirulent and Immunogenic: Implications for a Genital Herpes Vaccine
William P. Halford et al.
PLOS ONE (2010)
A phase I evaluation of inactivated influenza A/H5N1 vaccine administered by the intradermal or the intramuscular route
Shital M. Patel et al.
VACCINE (2010)
Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infection
William J. Muller et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Current Concepts: Maternal and Neonatal Herpes Simplex Virus Infections.
Lawrence Corey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Asymptomatic shedding of herpes simplex virus 1 and 2: Implications for prevention of transmission
Gregory J. Mertz
JOURNAL OF INFECTIOUS DISEASES (2008)
Genital herpes and its management
P. Sen et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
EE Freeman et al.
AIDS (2006)
Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students
CM Roberts et al.
SEXUALLY TRANSMITTED DISEASES (2003)
Natural history of genital herpes simplex virus type 1 infection
R Engelberg et al.
SEXUALLY TRANSMITTED DISEASES (2003)
Glycoprotein-D-adjuvant vaccine to prevent genital herpes
LR Stanberry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10△PK
T Gyotoku et al.
VACCINE (2002)
Longitudinal stud of genital infection by herpes simplex virus type 1 in western Scotland over 15 years
A Scoular et al.
BRITISH MEDICAL JOURNAL (2002)
A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs
M Wachsman et al.
VACCINE (2001)
Construction, phenotypic analysis, and immunogenicity of a UL5/UL29 double deletion mutant of herpes simplex virus 2
X Da Costa et al.
JOURNAL OF VIROLOGY (2000)
Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons
A Wald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
